BOSTON LIFE SCIENCES INC /DE
10-Q, EX-27.1, 2000-08-11
PHARMACEUTICAL PREPARATIONS
Previous: BOSTON LIFE SCIENCES INC /DE, 10-Q, 2000-08-11
Next: STRONG CAPITAL MANAGEMENT INC ET AL, 13F-HR, 2000-08-11



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from financial statements
as reported on Form 10-Q and is qualified in its entirety by reference to such
financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       4,628,538
<SECURITIES>                                17,781,978
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            22,825,408
<PP&E>                                         258,739
<DEPRECIATION>                                 210,595
<TOTAL-ASSETS>                              23,065,152
<CURRENT-LIABILITIES>                        1,484,965
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       204,225
<OTHER-SE>                                  21,375,962
<TOTAL-LIABILITY-AND-EQUITY>                23,065,152
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                6,294,809
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             344,870
<INCOME-PRETAX>                            (6,279,349)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (6,279,349)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (6,279,349)
<EPS-BASIC>                                     (0.34)
<EPS-DILUTED>                                   (0.34)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission